Last reviewed · How we verify
NCT06340945
The Outcomes of Ultrasound-guided Thermal Ablation for Benign Thyroid Nodules
NA trial testing ultrasound-guided thermal ablation in Thyroid Nodules in 1,500 participants. Currently enrolling.
31 December 2027
Quick facts
| Lead sponsor | Chinese PLA General Hospital |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | sequential |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 1,500 |
| Start date | 1 April 2024 |
| Primary completion | 31 December 2027 |
| Estimated completion | 31 December 2029 |
| Sites | 1 location across China |
Drugs / interventions tested
- ultrasound-guided thermal ablation
Conditions studied
- Thyroid Nodules — all drugs for Thyroid Nodules →
Sponsor
Chinese PLA General Hospital
Who can join
18 and older, any sex, with Thyroid Nodules. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
1. To evaluate the clinical outcomes of ultrasound-guided thermal ablationfor the treatment of benign thyroid nodules; 2. To develop and validate a artificial intelligence model to predict the outcomes of ultrasound-guided thermal ablation in the treatment of benign thyroid nodules
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06340945
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of ultrasound-guided thermal ablation
Trials testing the same drug.
- NCT06733740 — Ultrasound-guided Thermal Ablation for Papillary Thyroid Carcinoma · recruiting
- NCT06733766 — Ultrasound-guided Thermal Ablation for Recurrent Thyroid Cancer · recruiting
- NCT06733753 — Ultrasound-guided Thermal Ablation for Bethesda III/IV Thyroid Nodules · recruiting
- NCT06729762 — Ultrasound-guided Thermal Ablation for Benign Thyroid Nodules · recruiting
- NCT06316895 — The Clinical Outcomes and Prediction of Thermal Ablation for Low-risk Papillary Thyroid Carcinoma · recruiting
Other recruiting trials for Thyroid Nodules
Currently open trials in the same condition.
- NCT07360587 — Thyroid Artery Embolization for the Treatment of Compressive Goiters. · NA · recruiting
Other Chinese PLA General Hospital trials
Trials by the same sponsor.
- NCT07294755 — The Impact of Intrapleural Block on Postoperative Pain Caused by Drainage Tubes After Thoracoscopic Surgery · NA · not yet recruiting
- NCT07536607 — Predictive Role of Photon Counting Computed Tomography in Acute Coronary Syndrom Patients · not yet recruiting
- NCT07489157 — Real-Time End-Tidal Carbon Dioxide Monitoring for Early Warning of Hypoxemia in Painless Gastrointestinal Endoscopy · NA · not yet recruiting
- NCT07494981 — Individualized Precision Therapy With Ceftazidime and Avibactam Guided by PK/PD in Geriatric Populations · not yet recruiting
- NCT07496008 — Individualized Precision Isavuconazole Therapy Guided by PK/PD Principles for the Geriatric Population · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06340945 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Chinese PLA General Hospital
- Last refreshed: 19 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06340945.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing